Figure 17.1
Chest X-ray with normal heart size and no significant parenchymal abnormalities
Because of significant symptoms, further assessment was pursued. Echocardiogram was notable for normal systolic left ventricular (LV) function with ejection fraction of 55%. Right ventricle was mild to moderately dilated. Tricuspid valve was moderate to severely regurgitant and pulmonary pressures were estimated at 78 mmHg.
His abnormal echocardiogram prompted further evaluation of the etiology and severity of his elevated pulmonary pressures. Additional laboratory assessment revealed normal thyroid function and no significant abnormalities on autoimmune workup. Pulmonary function testing (Table 17.1) did not reveal significant changes that could account for severity of elevated pulmonary pressures.
Table 17.1
Pulmonary function test without significant obstruction or restriction. Diffusing capacity was mildly decreased
FEV1 (L) | 2.96 |
FEV1% | 89 |
FVC (L) | 4.31 |
FVC% | 92 |
FEV1/FVC (%) | 69 |
TLC (L) | 6.56 |
TLC% | 98 |
RV | 1.52 |
RV% | 65 |
VC | 5.04 |
VC% | 1.08 |
DLCO (mL/mmHg s) | 19.5 |
DLCO % | 78 |
Additional imaging was performed to assess for possibility of pulmonary embolism as etiology of his progressive shortness of breath and echocardiographic findings. Ventilation (Fig. 17.2)/perfusion (Fig. 17.3) scanning was performed and revealed bilateral patchy perfusion defects without significant ventilation abnormalities.
Based on V/Q, there was concern for chronic thromboembolic pulmonary hypertension (CTEPH). A more definitive evaluation with CT pulmonary angiogram (CTPA) (Fig. 17.4) was therefore requested. CTPA revealed enlarged pulmonary arteries but no evidence of significant parenchymal lung disease or pulmonary emboli.